Internal Medicine, Rheumatology · Daytona Beach, FL
NPI
1659363505
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1893 N Clyde Morris Blvd, Suite 110
Daytona Beach, FL, 32117
Phone (386) 676-0307
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
218,523 services
Medicare patients, 2024
864
Average age 74
Drug cost, 2024
$7.7M
10,203 prescriptions
Company payments, 2025
$649
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yong H Tsai was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 138,400 times for 39 patients. In total Yong H Tsai billed 218,523 services in 60 codes, and Medicare paid $1.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 138,400 | 39 | $3.62 | $502K |
| J0897 Injection, denosumab, 1 mg | Office | 9,840 | 101 | $20.03 | $197K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 7,300 | 38 | $24.74 | $181K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 5,575 | 11 | $33.71 | $188K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,483 | 65 | $0.10 | $460 |
| 95004 Test - Miscellaneous | Office | 2,138 | 33 | $2.97 | $6,342 |
| 99214 Office E&M - Established | Office | 1,083 | 564 | $94.37 | $102K |
| 96401 Chemotherapy Administration | Office | 911 | 135 | $57.35 | $52K |
| 95165 Treatment - Miscellaneous | Office | 748 | 24 | $11.55 | $8,642 |
| 95044 Test - Miscellaneous | Office | 740 | 12 | $3.81 | $2,820 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 557 | 442 | $13.71 | $7,637 |
| 95117 Treatment - Miscellaneous | Office | 441 | 33 | $8.65 | $3,814 |
| 95024 Test - Miscellaneous | Office | 441 | 15 | $5.73 | $2,528 |
| 96413 Chemotherapy Administration | Office | 388 | 75 | $103.06 | $40K |
| 99213 Office E&M - Established | Office | 311 | 232 | $64.27 | $20K |
By year: 2022 $2.1M for 203,128 services; 2023 $2.2M for 211,184 services; 2024 $1.9M for 218,523 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yong H Tsai prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,387 prescriptions and refills. In total Yong H Tsai wrote 10,203 Medicare prescriptions that cost $7.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,387 | 2,997 | 385 | $29K |
| Hydroxychloroquine Sulfate Generic | 1,362 | 3,113 | 409 | $43K |
| Prednisone Generic | 1,345 | 2,473 | 456 | $11K |
| Alendronate Sodium Generic | 552 | 1,189 | 178 | $3,273 |
| Tramadol Hcl Generic | 464 | 468 | 122 | $3,562 |
| Leflunomide Generic | 391 | 847 | 112 | $20K |
| Gabapentin Generic | 329 | 637 | 111 | $4,856 |
| Meloxicam Generic | 223 | 482 | 66 | $1,527 |
| Folic Acid Generic | 221 | 576 | 77 | $1,602 |
| Allopurinol Generic | 212 | 521 | 56 | $1,843 |
| Montelukast Sodium Generic | 150 | 362 | 67 | $1,829 |
| Triamcinolone Acetonide Generic | 140 | 163 | 72 | $1,546 |
| Ipratropium Bromide Generic | 124 | 158 | 57 | $3,570 |
| Sulfasalazine Generic | 123 | 273 | 32 | $2,989 |
| Duloxetine Hcl Generic | 119 | 253 | 33 | $3,875 |
Brand drugs: 1,412 claims; generic drugs: 8,771 claims; opioid claims: 597.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yong H Tsai $649 ($649 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $317.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.